Key result
A case series and proposed protocol describe the management of dental patients taking direct oral anticoagulants such as dabigatran.
Case Report
This case series proposes a protocol for the management of dental patients taking direct oral anticoagulants like dabigatran.
Experience with DOAC dental patients supports protocol consideration; should not yet change practice pending higher-level evidence.
Direct oral anticoagulants (DOACs) are increasingly used as alternatives to warfarin because of the superior pharmacokinetic properties. Clinical guidelines on the influences of DOACs for dental procedures have emerged, but all of necessity based on low-quality available evidence. Herein, we share our experience with a case series, and propose a protocol regarding the management of dental patients taking DOACs.
No takes yet. Share an insight, caveat, or question.
Hassona et al. (2018) conducted a case report in Dental patients taking direct oral anticoagulants (Dabigatran). Direct oral anticoagulants (Dabigatran) was evaluated. A case series and proposed protocol describe the management of dental patients taking direct oral anticoagulants such as dabigatran.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: